Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Microcapsules comprising sunscreen agents

a technology of sunscreen agent and microcapsule, which is applied in the preparation of microcapsules, chemistry apparatus and processes, and colloidal chemistry. it can solve the problems of in vivo evidence of nanoparticulate toxicity, damage applied therewith, grainy and occlusive qualities, etc., and achieves the effect of reducing hazardous effects, increasing the sun protection factor, and eliminating cosmetic drawbacks related to the appearance of sunscreen formulation on the skin

Inactive Publication Date: 2016-01-14
TAGRA BIOTECH
View PDF5 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent text discusses the need for safer sunscreen products that provide better sun protection without causing negative cosmetic effects on the skin. Additionally, the patent aims to reduce the hazardous effects of UV filters currently used in sunscreen formulations. The technical effect of the patent is to develop safer sunscreen products with improved sun protection factor (SPF) while minimizing the adverse side effects of current UV filters.

Problems solved by technology

In addition to cosmetic drawbacks, widespread application of early formulations containing TiO2 or ZnO was further hindered by their poor dispersive properties which resulted in grainy and occlusive qualities.
Recently, it was reported, on the basis of in vitro cell experiments, that pure TiO2 or ZnO nanoparticles can induce free radical formation in the presence of light and that this may damage applied therewith.
Currently, there is no in vivo evidence to indicate possible toxicity of nanoparticulate TiO2 or ZnO in humans using sunscreen products.
Thus, an analysis of the available evidence fails to demonstrate toxicity of these products after cutaneous application to healthy, intact skin.
However, oxybenzone is the most common cause of photoallergic contact dermatitis.
These microcapsules were designed to permanently encapsulate the sunscreen agents, but a significant amount of leakage of the sunscreen agents through the microcapsules was observed when the microcapsules were incorporated into usual sunscreen compositions, particularly when the microcapsules were of size smaller than 3 μm.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Microcapsules comprising sunscreen agents
  • Microcapsules comprising sunscreen agents
  • Microcapsules comprising sunscreen agents

Examples

Experimental program
Comparison scheme
Effect test

example 1

Preparation of Microcapsules Containing TiO2

[0241]1.1 Preparation of Organic Phase / Master Batch (MB) Stage

[0242]An organic phase (herein referred to interchangeably as “master batch” (MB)) was prepared by gradually adding 20 grams of the wall-forming polymer poly(methyl methacrylate) (PMMA) under stiffing (5 minutes), into 233.3 grams of ethyl acetate, heating to 50° C. and stirring well until the mixture was homogeneous and transparent (about 20 minutes). The obtained polymer solution was cooled to 25° C. TiO2 was added to the solution under stiffing for about 5 minutes and then the mixture was homogenized for about 8 minutes. The components of the MB are presented in Table 1.

TABLE 1Master batch constituentsLoading for 100 gramsMaterialMB1PMMA (average MW ca. 15,000; Sigma-20Aldrich ®, IL)2TiO2 (UV-TITAN M262, Sachtleben,80Germany)3Ethyl acetate (Sciencelab.com, Inc., USA)233.3

[0243]1.2 Preparation of the Emulsion

[0244]An aqueous solution of 0.4% polyvinyl alcohol (PVA) was prepar...

example 2

Preparation of Microcapsules Containing Avobenzone

2.1 Preparation of Master Batch (MB)

[0251]A master batch was prepared under light protection conditions by gradually adding 50 grams of the wall-forming polymer PMMA, under stiffing (5 minutes), into 300 grams of ethyl acetate in a vessel, heating to 50° C. and dissolving PMMA under stiffing (about 20 minutes) to a homogeneous and transparent solution. The polymer solution was than cooled to 25° C., and octocrylene (10 grams) was added to the polymer solution under stiffing for about 3 minutes. 1-(4-methoxyphenyl)-3-(4-tert-butylphenyl)propane-1,3-dione (avobenzone; 40 grams) was then added to the mixture under stiffing for 5 minutes. The components of the MB are presented in Table 4.

TABLE 4MB constituentsLoading component of MBMaterial(grams)-(for 100 grams)1PMMA502Octocrylene (UNIPROMA,10China)3Avobenzone (Neo Heliopan ® 357,4095% 4Ethyl Acetate300

[0252]2.2 Preparation of the Emulsion

[0253]An aqueous solution was prepared by mixing...

example 3

Preparation of Body Lotion Sunscreen Formulation

[0256]Body lotion sunscreen formulations comprising sunscreens-containing microcapsules of some embodiments of the present invention and the ingredients listed in Table 7 below were prepared by combining 4 phases prepared separately, as follows:

[0257]Phase 1 was obtained by mixing altogether the ingredients listed in Table 7 and heating to 70° C.

[0258]Phase 2, the stabilizing gel was prepared by mixing glycerin into water, followed by slow addition of the gelling-emulsifying agent Ecogel™ in order to increase viscosity and avoid clumping. The mixture was heated to 70° C. under mixing, and further mixed whilst maintaining this temperature for additional 20 minutes.

[0259]Phase 3, the sunscreen agent dispersion, was prepared by adding sunscreen agent-containing microcapsules according to some embodiments of the present invention, for example, microcapsules containing TiO2, to the dispersing agent Crodasperse™ (particularly useful for inor...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
particle sizeaaaaaaaaaa
Login to View More

Abstract

Microcapsules comprised of a core comprising one or more sunscreen agents and a shell of a wall-forming polymeric material, which are non-rupturable upon rubbing or pressing on the skin, and processes of preparing same are disclosed. Topical formulations comprising the microcapsules, which can be, for example, sunscreen formulations or skin care formulations, are also provided.

Description

FIELD AND BACKGROUND OF THE INVENTION[0001]The present invention, in some embodiments thereof, relates to microcapsules suitable for use in topical compositions and, more particularly, but not exclusively, to microcapsules comprising sunscreen agents and to topical formulations comprising same, which can be used, for example, in cosmetic formulations, such as sunscreen and skincare formulations.[0002]The detrimental effects of UV exposure to the sun have been well described in the literature. Both acute and chronic UV exposures can lead to sunburn, photocarcinogenesis, photo-immunosuppression and photoaging. While the photoprotective benefits of the inorganic UV filters TiO2 and ZnO have been known for decades, these earlier generations of inorganic filters, comprised of large particles, produce an opaque and white appearance on the skin. In addition to cosmetic drawbacks, widespread application of early formulations containing TiO2 or ZnO was further hindered by their poor dispersi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/11A61K8/29A61K8/35A61K8/81A61Q17/04
CPCA61K8/11A61Q17/04A61K8/29A61K8/35A61K2800/805A61K2800/262A61K2800/412A61K2800/52A61K2800/30A61K8/8152A61K8/40A61Q19/00
Inventor GOLDSTEIN, DANNYPRIVALOVA, OLGABEN-ALTABET, LIORMENACHEM, YANIVHAJ, HANAN
Owner TAGRA BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com